Zobrazeno 1 - 10
of 46
pro vyhledávání: ''
Autor:
Ralph Wäsch, Robert Zeiser, Hartmut Bertz, Reinhard Marks, Gabriele Ihorst, Jesus Duque-Afonso, Mehtap Yücel, Jürgen Finke, TC Köhler, Joachim Müller-Quernheim, Miguel Waterhouse
Publikováno v:
Bone Marrow Transplantation
The age of patients undergoing allogeneic hematopoietic cell transplantation (allo-HCT) has increased during the last decades, mainly due to improved reduced-intensity/toxicity conditioning protocols. A reduced-intensity conditioning based on fludara
Autor:
Patrizia Chiusolo, Sabrina Giammarco, Carmen Di Grazia, Maria Teresa Van Lint, Federica Sorà, Andrea Bacigalupo, Emanuele Angelucci, Anna Maria Raiola, Alida Dominietto, Luca Laurenti, Francesca Gualandi
Publikováno v:
Bone Marrow Transplantation. 54:708-712
This is an update on acute and chronic graft-versus-host disease (GvHD) in 425 patients with hematologic malignancies, undergoing an unmanipulated haploidentical (HAPLO) graft from related donors, with a modified post-transplant cyclophosphamide (PT-
Autor:
Marcie L. Riches, Jaime S. Green, Maheen Z. Abidi, Dwight E Yin, Taiga Nishihori, Min Chen, Celalettin Ustun, Caroline A. Lindemans, John R. Wingard, Joshua A. Hill, Baldeep Wirk, Robert Peter Gale, Usama Gergis, Richard F. Olsson, Parameswaran Hari, Hillard M. Lazarus, Gerhard C. Hildebrandt, Jeffrey Auletta, Krishna V. Komanduri, Sachiko Seo, David Marks, Minoo Battiwala, Miguel Angel Diaz, Parastoo B. Dahi, Jean A. Yared, Soyoung Kim, Siddhartha Ganguly
Publikováno v:
Bone Marrow Transplantation, 54(8), 1354. Nature Publishing Group
Bone marrow transplantation, vol 54, iss 8
Bone marrow transplantation, vol 54, iss 8
Limited data exist on characteristics of central nervous system viruses (CNS-V) in allogeneic hematopoietic stem cell transplant (HCT) recipients. Between 2007 and 2015, the Center for International Blood and Marrow Transplant Research (CIBMTR) recei
Autor:
Lining Wang, Liang Tian, Didier Blaise, Xing Fan, Jiong Hu, Raynier Devillier, Sabine Furst, Justine Decroocq, Ling Wang, Ming Wan, Norbert Vey
Publikováno v:
Bone Marrow Transplantation
The purpose of the study was to evaluate the feasibility of conditioning regimen with sequential chemotherapy (FLAG-IDA), followed by Fludarabine (5 days) + Busulfan (3 days) by parallel analysis of patients with refractory acute myeloid leukemia (AM
Autor:
Maria Teresa Van Lint, Stefania Bregante, Emanuele Angelucci, Elisabetta Metafuni, Simona Sica, Patrizia Chiusolo, Andrea Bacigalupo, Alida Dominietto, Luca Laurenti
Publikováno v:
Bone Marrow Transplantation
We studied 97 patients who developed cytomegalovirus (CMV) viremia following an allogeneic hemopoietic stem cell transplant (HSCT) between 2010 and 2015, treated with foscarnet, with the aim of assessing efficacy and safety. The donor was unrelated i
Autor:
Çiğdem Gereklioğlu, Cagla Sariturk, Mahmut Yeral, Can Boga, Pelin Aytan, Nurhilal Büyükkurt, Soner Solmaz, Aslı Korur, Hakan Ozdogu, Ilknur Kozanoglu, Süheyl Asma, Mutlu Kasar
Publikováno v:
Bone Marrow Transplantation. 53:880-890
Adult patients with sickle cell disease (SCD) are highly susceptible to stem cell transplant complications, including drug toxicity, graft versus host disease (GVHD), and graft rejection due to SCD-related tissue damage, endothelial activation, and i
Publikováno v:
Bone Marrow Transplantation. 53:647-650
Autor:
Rosendo Perez-Fontalvo, Martin Castro, Miguel Angel Herrera-Rojas, Amado Kardduss-Urueta, Iván Murrieta-Álvarez, Nancy Labastida-Mercado, César Homero Gutiérrez-Aguirre, Guillermo J. Ruiz-Argüelles, Giovanni Ruiz-Rojas, Guillermo J. Ruiz-Delgado, Gregorio Jaimovich, David Gómez-Almaguer, Robert Peter Gale, María Angélica Cardona-Molina, Samantha Galindo-Becerra, Leonardo Feldman, Alicia Endara
Publikováno v:
Bone Marrow Transplantation. 53:457-460
We studied rates of granulocyte and platelets recovery in 359 consecutive subjects receiving blood cell infusions in the context of autotransplants for plasma cell myeloma (N = 216) and lymphomas (N = 143). Blood cells were mobilised with filgrastim
Autor:
Michelly Kerly Sampaio de Melo, Yana Novis, Carolina Atallah Pontes da Silva, Vanderson Rocha, Roberta Shcolnik Szor, Luciana Tucunduva, Mariana Serpa, Erick Xavier, Aliana Meneses Ferreira, Ana Rita Brito Medeiros da Fonseca, André Domingues Pereira, Celso Arrais-Rodrigues
Publikováno v:
Bone Marrow Transplantation. 53:503-506
Autor:
Abhinav Deol, Edmund K. Waller, Z Gul, Zaid Al-Kadhimi, Muneer H. Abidi, Lawrence G. Lum, Amelia Langston, Wei Chen, C Ozust, Hyejeong Jang, Joseph P. Uberti
Publikováno v:
Bone Marrow Transplantation. 52:1304-1310
Chronic GvHD (cGvHD) is the leading cause of late non-relapse mortality (NRM) and morbidity after allogeneic hematopoietic stem cell transplant (AHSCT). We analyzed the late effects of a phase II trial testing the efficacy of intermediate dose rabbit